Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infection
Biotech
X4 scores a phase 3 win for immune deficiency disorder drug
Four months after laying off staff, X4 says its WHIM syndrome therapy improved white blood cell counts in patients during a phase 3 trial.
Annalee Armstrong
Nov 30, 2022 10:45am
Could a single pill outsmart a tumor's resistance mechanisms?
Mar 29, 2021 10:00am
Gilead snaps ups German virology biotech MYR
Dec 10, 2020 8:55am
Takeda's maribavir hits phase 3 goal
Dec 4, 2020 8:47am
Finch nets $90M to push C. diff microbiome med toward FDA filing
Sep 17, 2020 7:00am
Lumen hires Spigarelli to lead infectious disease work
Sep 10, 2020 8:35am
